Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.

Prehypertension ups risk of cardiovascular diseases, stroke

13 Dec 2019
Prehypertension has been omitted in the new guideline. Source: LiveScience/AHA

Prehypertension, particularly in the high range, appears to heighten the risk of total cardiovascular diseases (CVDs), coronary heart disease (CHD), myocardial infarction (MI) and stroke, according to the results of a systematic review and meta-analysis.

The investigators conducted a detailed search of PubMed, Embase and Web of Science for articles published through 7 November 2018. Normal range blood pressure was defined as systolic (S)BP <120 mm Hg and diastolic (D)BP <80 mm Hg.

Risk ratios (RRs) and 95 percent confidence intervals (CIs) were pooled using fixed effects models. The heterogeneity among subgroups was estimated through meta-regression.

Twenty-seven articles (47 studies including 491,666 participants) met the eligibility criteria. Prehypertension showed a significant correlation with total CVDs (RR, 1.40, 95 percent CI, 1.34–1.46), CHD (RR, 1.40, 95 percent CI, 1.28–1.52), MI (RR, 1.86, 95 percent CI, 1.50–2.32) and stroke (RR, 1.66, 95 percent CI, 1.56–1.76).

Low-range (120–129/80–84 mm Hg) prehypertension vs normal BP increased the risk of total CVDs (RR, 1.42, 95 percent CI, 1.29–1.55), MI (RR, 1.43, 95 percent CI, 1.10–1.86) and stroke (RR, 1.52, 95 percent CI, 1.27–1.81), while high-range (130–139/85–89 mm Hg) prehypertension increased the risk of total CVDs (RR, 1.81, 95 percent CI, 1.56–2.10), CHD (RR, 1.65, 95 percent CI, 1.13–2.39), MI (RR, 1.99, 95 percent CI, 1.59–2.50) and stroke (RR, 1.99, 95 percent CI, 1.68–2.36).

The population-attributable risk for the association of total CVDs, CHD, MI and stroke with prehypertension was 12.09 percent, 13.26 percent, 24.60 percent and 19.15 percent, respectively.

“Effective control of prehypertension could prevent more than 10 percent of CVD cases,” the investigators said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.